Position in URGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,870,649
-$2,633,986 QoQ
Shares Held
159,658
-32.1% QoQ
Ownership
0.328%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. URGN ranks #185 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in URGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,870,649 | 159,658 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,504,635 | 235,040 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,600,176 | 180,460 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,226,819 | 308,527 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,974,351 | 1,173,088 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,826,733 | 922,698 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $581,342 | 45,775 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $199,463 | 11,887 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $643,005 | 42,867 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $376,035 | 25,069 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $269,258 | 19,219 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $146,016 | 14,108 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $201,127 | 22,675 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $362,659 | 43,589 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $211,875 | 25,870 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $473,223 | 54,331 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $453,208 | 47,656 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,051 | 1,311 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,743 | 900 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $146,528 | 7,522 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $214,906 | 11,926 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $49,015 | 2,541 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $237,718 | 9,101 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $204,446 | 11,460 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||